216 related articles for article (PubMed ID: 10368803)
1. [Interferon beta-1b. New therapy for patients with secondary progressive multiple sclerosis].
Nervenarzt; 1999 May; 70(5 Suppl):1-12. PubMed ID: 10368803
[No Abstract] [Full Text] [Related]
2. [Interferon therapy of multiple sclerosis].
Jensen D
Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
[TBL] [Abstract][Full Text] [Related]
3. [Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland].
Huber S; Spycher M; Lechner-Scott J; Bellaiche Y; Steck AJ; Kappos L
Schweiz Med Wochenschr; 1996 Aug; 126(35):1475-81. PubMed ID: 8927950
[TBL] [Abstract][Full Text] [Related]
4. [A short history of beta-interferon therapy of multiple sclerosis].
Stock G; Horowski R
Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.
Horowski R; Stürzebecher CS; Kapp JF
Funct Neurol; 2001; 16(2):117-28. PubMed ID: 11495417
[No Abstract] [Full Text] [Related]
6. [New trends, clinical questions and long-term experiences. Therapy of multiple sclerosis with interferon beta-1b].
Nervenarzt; 1998 Nov; 69(11 Suppl Therapie D):1-8. PubMed ID: 9845885
[No Abstract] [Full Text] [Related]
7. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.
Petkau J; White R
Mult Scler; 1997 Dec; 3(6):402. PubMed ID: 9493643
[No Abstract] [Full Text] [Related]
8. Early treatment.
Comi G
Neurol Sci; 2006 Mar; 27 Suppl 1():S8-12. PubMed ID: 16708191
[TBL] [Abstract][Full Text] [Related]
9. Interferon causes no myasthenia in a seropositive patient with multiple sclerosis.
Shimizu H; Kataoka H; Kawahara M; Hirano M; Furiya Y; Ueno S
Clin Neurol Neurosurg; 2007 Apr; 109(3):277-8. PubMed ID: 17118531
[TBL] [Abstract][Full Text] [Related]
10. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
[No Abstract] [Full Text] [Related]
11. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
12. Interferon beta in the treatment of multiple sclerosis--closing remarks.
Kappos L
Mult Scler; 1995; 1 Suppl 1():S64-6. PubMed ID: 9345403
[No Abstract] [Full Text] [Related]
13. Patients' views of interferon therapy in MS.
Burgess M
Prof Nurse; 1998 Jun; 13(9):588-92. PubMed ID: 9782975
[TBL] [Abstract][Full Text] [Related]
14. 10 years of interferon beta-1b (Beta feron therapy.
Kappos L; Hartung HP
J Neurol; 2005 Sep; 252 Suppl 3():iii1-iii2. PubMed ID: 16170493
[No Abstract] [Full Text] [Related]
15. Overview of European pilot study of interferon beta-Ib in primary progressive multiple sclerosis.
Montalban X
Mult Scler; 2004 Jun; 10 Suppl 1():S62; discussion 62-4. PubMed ID: 15218812
[TBL] [Abstract][Full Text] [Related]
16. New treatments for multiple sclerosis.
Hutchinson M
Ir Med J; 1996; 89(2):44. PubMed ID: 8682623
[No Abstract] [Full Text] [Related]
17. Interferon-beta1a treatment for multiple sclerosis.
Sandberg-Wollheim M
Expert Rev Neurother; 2005 Jan; 5(1):25-34. PubMed ID: 15853471
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-beta-1b treatment of disseminated sclerosis].
Sørensen S
Ugeskr Laeger; 1997 Feb; 159(6):779-84. PubMed ID: 9045474
[No Abstract] [Full Text] [Related]
19. Disease-modifying drugs for the early treatment of multiple sclerosis.
Flachenecker P
Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
[TBL] [Abstract][Full Text] [Related]
20. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
de Haan RJ; Polman CH
Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2168-71. PubMed ID: 8984352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
